The World Health Organization commissioned reviews to inform upcoming guidelines on GLP-1 drugs to treat obesity – they are also touted as reducing other addiction cravings. The drugs resulted in clinically meaningful weight loss compared with placebo – but evidence on longer-term outcomes and side effects is uncertain.
Search
News Archives
News Signup
FREE: daily or weekly news supporting freedom from dependency
Journal signup
FREE: print journal and emag supporting freedom from dependency
Conference savings
MONEY OFF: for signups
Support our work
To support us giving the recovery field FREE daily news+research, FREE library, FREE journal and subsidised conference training, click the secure Donate link. THANK YOU!
Recent News
